Nisa Investment Advisors, LLC Abb Vie Inc. Transaction History

Nisa Investment Advisors, LLC

$15.2 Billion
Q1 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 516,863 shares of ABBV stock, worth $88.7 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

516,863

Previous 477,555 8.23%

Holding current value

$88.7 Million

Previous $74 Million 27.18%

% of portfolio

0.62%

Previous 0.53%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $6.28 Million - $7.16 Million	39,308 Added 8.23%	516,863 $94.1 Million
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $1.31 Million - $1.47 Million	-9,514 Reduced 1.95%	477,555 $74 Million
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $4.59 Million - $5.32 Million	-34,386 Reduced 6.59%	487,069 $72.6 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $1.41 Million - $1.76 Million	10,658 Added 2.09%	521,455 $70.3 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $3.56 Million - $4.1 Million	24,640 Added 5.07%	510,797 $81.4 Million

Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $2.45 Million - $2.94 Million	-17,749 Reduced 3.52%	486,157 $78.6 Million
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $3.87 Million - $4.44 Million	28,859 Added 6.07%	503,906 $67.8 Million
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $2.08 Million - $2.65 Million	-15,148 Reduced 3.09%	475,047 $72.8 Million
Q1 2022 Apr 29, 2022	BUY	$131.98 - $163.75 $2.6 Million - $3.23 Million	19,697 Added 4.19%	490,195 $79.5 Million
Q4 2021 Feb 03, 2022	SELL	$107.43 - $135.93 $2.5 Million - $3.17 Million	-23,296 Reduced 4.72%	470,498 $64.4 Million
Q3 2021 Oct 18, 2021	SELL	$106.4 - $120.78 $3.45 Million - $3.92 Million	-32,468 Reduced 6.17%	493,794 $53.3 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $1.64 Million - $1.83 Million	-15,579 Reduced 2.88%	526,262 $59.3 Million
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $1.44 Million - $1.58 Million	-14,040 Reduced 2.53%	541,841 $58.6 Million
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $3.85 Million - $5.2 Million	-47,836 Reduced 7.92%	555,881 $59.6 Million
Q3 2020 Oct 20, 2020	SELL	$85.91 - $100.83 $867,605 - $1.02 Million	-10,099 Reduced 1.65%	603,717 $52.9 Million
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $9 Million - $12 Million	122,672 Added 24.98%	613,816 $60.3 Million
Q1 2020 Apr 17, 2020	SELL	$64.5 - $97.79 $399,900 - $606,298	-6,200 Reduced 1.25%	491,144 $37.4 Million
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $1.7 Million - $2.13 Million	-23,615 Reduced 4.53%	497,344 $44 Million
Q3 2019 Oct 17, 2019	SELL	$62.98 - $75.72 $2.14 Million - $2.57 Million	-33,991 Reduced 6.13%	520,959 $39.4 Million
Q2 2019 Jul 12, 2019	SELL	$65.7 - $83.98 $353,268 - $451,560	-5,377 Reduced 0.96%	554,950 $40.4 Million
Q1 2019 Apr 17, 2019	BUY	$77.14 - $90.79 $1.47 Million - $1.73 Million	19,083 Added 3.53%	560,327 $45.2 Million
Q4 2018 Jan 17, 2019	SELL	$77.85 - $96.01 $1.58 Million - $1.95 Million	-20,354 Reduced 3.62%	541,244 $49.9 Million
Q3 2018 Oct 16, 2018	BUY	$88.91 - $98.84 $707,101 - $786,074	7,953 Added 1.44%	561,598 $53.1 Million
Q2 2018 Jul 19, 2018	SELL	$89.78 - $106.23 $605,925 - $716,946	-6,749 Reduced 1.2%	553,645 $51.3 Million
Q1 2018 Apr 10, 2018	BUY	$92.01 - $123.21 $803,247 - $1.08 Million	8,730 Added 1.58%	560,394 $55.4 Million
Q4 2017 Jan 12, 2018	BUY	$89.56 - $98.21 $655,220 - $718,504	7,316 Added 1.34%	551,664 $53.4 Million
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $38 Million - $48.6 Million	544,348	544,348 $48.4 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Abb Vie Inc. Transaction History